Rankings
▼
Calendar
BSX Q4 2017 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena
BSX
Boston Scientific Corporation
$103B
Q4 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$2.4B
+9.9% YoY
Gross Profit
$1.6B
66.8% margin
Operating Income
$444M
18.4% margin
Net Income
-$615M
-25.5% margin
EPS (Diluted)
$-0.45
QoQ Revenue Growth
+8.4%
Cash Flow
Operating Cash Flow
$872M
Free Cash Flow
$793M
Stock-Based Comp.
$128M
Balance Sheet
Total Assets
$19.0B
Total Liabilities
$12.0B
Stockholders' Equity
$7.0B
Cash & Equivalents
$188M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.4B
$2.2B
+9.9%
Gross Profit
$1.6B
$1.4B
+12.4%
Operating Income
$444M
$318M
+39.6%
Net Income
-$615M
$124M
-596.0%
Revenue Segments
MedSurg
$915M
51%
Cardiovascular
$883M
49%
← FY 2017
All Quarters
Q1 2018 →